Delivery Order SPE2DB25D3404-SPE2DB25FUNVB
Award Date
6/12/25
Potential Completion Date
7/7/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZYMFENTRA 120 MG/ML PEN KITS, a medical product. The contract is a Delivery Order with a Firm Fixed Price and a ceiling value of $1,503.56. It has an ultimate completion date of July 3, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds...
This is a federal contract award by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of ZYMFENTRA 120 MG/ML PEN KITS, a medical product, with a firm fixed price of $1,503.56 and a completion date of June 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,007.12, is for the supply of ZYMFENTRA 120 MG/ML PEN KITS, a type of pharmaceutical product. The contract has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation, indicating open competition. This...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZYMFENTRA 120 MG/ML PEN (2PK)S, a medical product, with a ceiling value of $4,510.68 and a completion date of July 8, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ZYMFENTRA 120 MG/ML PEN (2PK)S, a pharmaceutical product, under a Firm Fixed Price contract with a ceiling value of $1,503.56 and a period of performance through April 8, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ZYMFENTRA 120 MG/ML PEN (2PK)S medical products. The contract has a ceiling value of $6,014.24 and a performance period extending to July 9, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This delivery order is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,503.56, is for the delivery of ZYMFENTRA 120 MG/ML PEN (2PK)S, a medical product. The contract is designated as a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 2-packs of ZYMFENTRA 120 MG/ML PEN, a pharmaceutical product. The contract has a ceiling value of $2,106.45 and is a firm fixed price delivery order. The award date is June 9, 2025 and the ultimate completion date is July 1, 2025. This contract is not set aside and is therefore open to competition. Amerisourcebergen Drug...
This federal contract award, valued at $3,007.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZYMFENTRA 120 MG/ML PEN (2PK)S, a pharmaceutical product, with a completion date of June 6, 2025. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,212.90 firm fixed-price delivery order is for the supply of ZYMFENTRA 120 MG/ML PEN (2PK)S, with a performance period extending through June 4, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...